Description
Dacomitinib is a specific and irreversible inhibitor of the ERBB family of kinases with IC50s of 6 nM, 45.7 nM and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively.
Molecular Formula
C24H25ClFN5O2
Storage
Store at room temperature
Boiling Point
665.7±55.0 ℃ at 760 mmHg
Vapour Pressure
0.0±2.0 mmHg at 25℃
Specification
Irreversible small-molecule tyrosine kinase inhibitor (TKI) of tyrosine kinase human epidermal growth factor receptors (HER) 1 (EGFR), HER2, and HER4, a drug candidate for the treatment of non-small cell lung carcinoma.